Skip to main content
TRUP logo

TRUP · Trupanion, Inc.

Track TRUP — free
$34.48 +0.18 (+0.52%) At close · Nov 13
Market Cap
$1.49B
Shares
43.27M
Volume · Nov 13 239.77K Avg daily vol (3M) 438.63K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$34.48 Open$34.30 Day$34.12–34.97 52W close$21.46–39.39 Avg vol 30d431K Short int3.9M · 9.1% of shares · 11.2d Short vol58% Last earningsNov 5, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 5

Up next

Feb 11, 2027 Est · unconfirmed · in 13 wks

Latest documents

2026
Nov 5
Earnings call
Record Q3 adjusted operating income and free cash flow

Trupanion reported Q3 2026 revenue of $405.6 million, adjusted operating income of $47 million and all-time-high free cash flow of $28.5 million. Full-year 2026 guidance calls for $1.59 billion to $1.597 billion in revenue and $179 million to $182 million in adjusted operating income.

6 source passages
Good afternoon, and welcome to Trupanion's third quarter 2026 Financial Results Conference Call. Total revenue for the quarter was $405.6 million, up 11% year-over-year. In total, adjusted operating income was $47 million in Q3, up 15% from last year. As a result, our free cash flow was $28.5 million, an all-time high, up from $23.9 million last year, and our 10th consecutive quarter of positive free cash flow. For the full year of 2026, we now expect total revenue in the range of $1.59 billion to $1.597 billion. We now expect total adjusted operating income to be between $179 million and $182 million, or 19% year-over-year growth at the midpoint. Open the document at this passage
Nov 5
Registration statement S-3ASR
Resale of 3,636,364 shares registered for Aflac

Trupanion registered up to 3,636,364 common shares for Aflac’s resale from time to time, with all proceeds going to Aflac. The shares represented 8.4% of Trupanion’s outstanding common stock as of October 29, 2026.

Read from the first part of this long document
4 source passages
This prospectus relates to an aggregate of up to 3,636,364 shares of our common stock, which may be offered for sale from time to time by the selling stockholder, Aflac Incorporated ("Aflac"). All proceeds from the sale of Shares under this prospectus will be for the account of the selling stockholder. As of October 29, 2026, we had 43,265,932 shares of common stock outstanding, including the 3,636,364 Shares, and no shares of preferred stock outstanding. Aflac Incorporated | 3,636,364 | 8.4% | 3,636,364 Open the document at this passage
Nov 5
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Revenue rises 11%; subscription enrollment grows 6%

For the nine months ended September 30, 2026, Trupanion reported total revenue of 1,182,576 (in thousands), up 11%, and subscription pets enrolled of 1,145,160, up 6%. Its Pets Best underwriting relationship will end after the third quarter of 2028.

Revenue $405.59M ▲ 10.5% Diluted EPS $0.21 ▲ 61.5%
Read from the MD&A section
5 source passages
### Comparison of the Three and Nine Months Ended September 30, 2026 and 2025 Total revenue | 405,593 | | 366,920 | | 11 | 1,182,576 | | 1,062,452 | | 11 Total subscription pets enrolled (at period end) | 1,145,160 | | 1,082,412 | | 6 | 1,145,160 | | 1,082,412 | | 6 We and Pets Best have agreed to end our relationship after the third quarter of 2028. Within our subscription business, we also provide "Powered by Trupanion" pet insurance product offerings marketed by third parties Open the document at this passage
Nov 5
Current report 8-K
Revenue rises 11%, net income reaches $9.3 million

Trupanion reported third-quarter revenue of $405.6 million, up 11%, net income of $9.3 million and free cash flow of $28.5 million for the quarter ended September 30, 2026; it also repurchased $25.0 million of stock.

Financial results
5 source passages
Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. Total revenue was $405.6 million, an increase of 11% compared to the third quarter of 2025. Net income was $9.3 million, or $0.21 per basic and diluted share, compared to net income of $5.9 million, or $0.14 per basic and $0.13 per diluted share, in the third quarter of 2025. Operating cash flow was $30.7 million and free cash flow was $28.5 million in the third quarter of 2026. During the third quarter of 2026, the Company repurchased approximately 0.8 million shares of TRUP common stock at an aggregate cost of approximately $25.0 million. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.56B
Trailing 12 months
Net income (TTM)
−$21.18M
Trailing 12 months
Revenue growth YoY
+10.5%
Year over year
Operating margin
1.8%
Trailing 12 months
P / E (TTM)
56.5
Trailing earnings · reciprocal yield 1.8%
FCF yield
5.8%
TTM · current market cap
Return on invested capital
23.2%
Trailing 12 months
Net cash
$292.37M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.5%
Year over year · more shares
Price change (1Y)
-12.5%
Trailing year
Short interest
9.1%
Latest settlement · 11.2 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. Trupanion delivered 24% subscription adjusted operating income growth and raised/narrowed full-year AOI guidance to $176–184M while announcing a $100M share repurchase program backed by a $44M insurance entity dividend. Net pet adds accelerated 39% on improved enrollment conversion and higher LTV.

Bullish
  • + Subscription adjusted operating income grew 24% YoY to $41.4M with margin expanding to 15%
  • + Net subscription pet adds accelerated 39% YoY with gross pet ads up 9% and LTV up 25%
  • + Full-year 2026 adjusted operating income guidance raised to a range of $176M–$184M (~19% growth at midpoint)
  • + Board authorized $100M share repurchase program following $44M insurance entity dividend approval
  • + Free cash flow grew to $19.2M in Q2 and operating cash flow reached $21M
Bearish
  • − Net income declined to $6.8M ($0.16/share) from $9.4M ($0.22/share), partly as prior year included a $7.8M one-time gain
  • − Total enrolled pets declined 2% YoY to 1,633,131 due to other business segment contraction
  • − Pet acquisition cost per pet rose to $299 from $276 YoY
  • − Veterinary inflation remains elevated at double-digit levels, pressuring pricing and claims costs

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Strong Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +29%
above
Price vs 50-day avg +24%
above
RSI (14) 68
neutral
MACD trend Positive
52-week position 73%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return +23%
trailing
6-month return +58%
trailing
YTD return −8%
this year
Relative strength +57%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $28 › 200d $27 — 50d above 200d
Institutional flow Distributing
169 of 202 funds reported for Sep 30 · net -698.7K sh shares · +17 new
Insider flow Distributing
Net -$1.5M over 90 days · 100% sells
Short interest Rising
9.07% of shares out · ▲ +6.8% MoM · 11.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
202 holders — mid 3-yr range
Squeeze score 80
high risk · 0–100
Fundamentals
Excellent
Revenue growth +12%
Y/Y
Gross margin 5%
expanding
EPS growth +296%
Y/Y
Free cash flow $75.4M
Valuation P/E 56.5
rich
Buyback $100.0M
authorized
Balance sheet $26.2M
net cash
Quant / Vol
risk profile
Very High
Volatility 48%
annualized · 1-yr
Max drawdown −46%
past year
ATR 4.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 8 of last 8
Latest guidance · from the Earnings Call filed Aug 5, 2026
Total revenue · full year of 2026 Raised $1.58B – $1.6B
Apr 30, 2026 $1.56B – $1.58B changed to Aug 5, 2026 $1.58B – $1.6B
prior FY $1.44B midpoint +10.6% Y/Y
Subscription revenue · full year of 2026 Raised $1.12B – $1.13B
Apr 30, 2026 $1.12B – $1.14B changed to Aug 5, 2026 $1.12B – $1.13B
Total adjusted operating income · full year of 2026 Non-GAAP Maintained $176M – $184M
Apr 30, 2026 $173M – $187M changed to Aug 5, 2026 $176M – $184M
Prior guidance period ended · from the Earnings Call filed Aug 5, 2026
Total revenue · third quarter of 2026 $399M – $405M
Total adjusted operating income · third quarter of 2026 $44M – $47M
Subscription revenue · third quarter of 2026 $284M – $287M
Guided vs delivered · last 8 settled
Total revenue third quarter of 2026
guided $399M – $405M
$405.59M Beat +0.9%
Total revenue second quarter of 2026
guided $386M – $392M
$392.93M Beat +1.0%
Total revenue first quarter of 2026
guided $376M – $382M
$384.05M Beat +1.3%
Total revenue full year 2025
guided $1.42B – $1.43B
$1.44B Beat +1.0%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+29% Bullish
Price vs 50-day avg
+24% Bullish
RSI (14)
68 Neutral
MACD trend
Positive Bullish
52-week position
73% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross) No cross
50d $28 › 200d $27 — 50d above 200d
Institutional flow Distributing
169 of 202 funds reported for Sep 30 · net -698.7K sh shares · +17 new
Insider flow Distributing
Net -$1.5M over 90 days · 100% sells
Short interest Rising
9.07% of shares out · ▲ +6.8% MoM · 11.2 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
202 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $21 Now $34 · 73% Range high $39
vs 200-day avg +29% vs 50-day avg +24%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP 37.1M First Six Months 2026 —
Average monthly retention 98.37% Three Months Ended June 30, 2026 filing —
Average pet acquisition cost (PAC) $307 Six Months Ended June 30, 2026 —
Fixed expenses (non-GAAP) non-GAAP 45.35M Six Months Ended June 30, 2026 —
Free cash flow 32.9M First Six Months 2026 —
Monthly average revenue per pet $86.62 Six Months Ended June 30, 2026 —
Net acquisition cost (non-GAAP) non-GAAP $19.18M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP New pet acquisition expense 22.81M
-1.11M Net of sign-up fee revenue
-1.23M Stock-based compensation expense
-15K Other business pet acquisition expense
-1.27M Pet acquisition expense for commission-based policies
= Net acquisition cost 19.18M
Operating cash flow 35.6M First Six Months 2026 —
Other business adjusted operating income (non-GAAP) non-GAAP 3.71M Six Months Ended June 30, 2026 —
Subscription acquisition cost (non-GAAP) non-GAAP 42.72M Six Months Ended June 30, 2026 —
Subscription adjusted operating income (non-GAAP) non-GAAP 79.78M Six Months Ended June 30, 2026 —
Subscription cost of paying veterinary invoices (non-GAAP) non-GAAP 385.17M Six Months Ended June 30, 2026 —
Subscription variable expenses (non-GAAP) non-GAAP 49.32M Six Months Ended June 30, 2026 —
Total adjusted operating income (non-GAAP) non-GAAP 83.49M Six Months Ended June 30, 2026 —
Total pets enrolled (at period end) 1,633,131 Six Months Ended June 30, 2026 —
Total subscription pets enrolled (at period end) 1,124,548 Six Months Ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Insurance - Property & Casualty — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TRUP
Trupanion, Inc.
this stock
$1.49B -7.7% +11.9% 56.5 9.1%
CB
Chubb Ltd
$143.56B +20.4% +6.5% 13.2 0.8%
PGR
Progressive Corp
$136.60B +3.5% +16.3% 11.9 1.3%
TKOMY
Tokio Marine Holdings, Inc.
$105.49B — — — 0.0%
TRV
Travelers Companies, Inc.
$82.64B +39.0% +5.2% 10.6 2.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
203
% held
76.8%
Reported
169 of 202
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
224
View
Short & Settlement
Short Interest Rising
Shares short
3.9M
Days to cover
11.2d
Change
+249.5K sh
View
Short Volume
Short vol %
58%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
294
Value
$7.7K
As of
Oct 13, 2026
View
Off-Exchange
Off-exchange %
42.8%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$1.5M
Buyers / Sellers
0 / 5
Buyers Sellers
View
Congressional Trades Sell
Member
Bradley S. Schneider
Amount
$50.0K–$100.0K
Traded
Dec 10, 2021
View
Financials
Financials
Revenue (FY)
$1.4B
Net income (FY)
$19.4M
EPS diluted
$0.45
View
Buybacks
Authorized
$100.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 5, 2026
This year
14

Trupanion reported third-quarter revenue of $405.6 million, up 11%, net income of $9.3 million and free cash flow of $28.5 million for the quarter ended September 30, 2026; it also repurchased $25.0 million of stock.

View
Proposed Sales
Value
$223.6K
Shares
6.5K
Filed
Nov 10, 2026
View
Exempt Offerings
Offering
$200.0M
Filed
Nov 2, 2020
View
Earnings & Events
Webcasts
Last webcast
Nov 5, 2026
View
Investor Relations
Latest news
Trupanion Recognized Among Canada…
Published
Nov 12, 2026
View

Performance

5D 20D 120D MTD YTD
TRUP -6.2% +22.6% +57.7% +14.4% -7.7%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -8.8% +23.8% +57.2% +14.6% -18.4%

Capital returns

Buyback program · as of Sep 30, 2026
Authorized
$100.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1371285 CUSIP 898202106 13F (30d) 164 filings 143 filers Visit website Investor relations